Adage Capital Partners
GRNAW

Adage Capital Partners’s GreenLight Biosciences Holdings, PBC Warrant GRNAW Stock Holding History

Adage Capital Partners’s Portfolio GRNAW Stock Details GRNAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-858,334
Closed -$927K – 1090
2021
Q2 		$927K Sell
858,334
-66,666
-7% -$58.9K ﹤0.01% 907
2021
Q1 		$805K Buy
+925,000
New +$964K ﹤0.01% 890

Other funds holding GRNAW

HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
MF
Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
OCAM
Owl Creek Asset Management New York $1.38B AUM 59.67% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return

Adage Capital Partners's GRNAW Position: Q3 2021 in Review

Adage Capital Partners sold out of GreenLight Biosciences Holdings, PBC Warrant (GRNAW) in Q3 2021, closing a stake of 858,334 shares — an estimated $927K sold.

Adage Capital Partners first reported a position in GRNAW in Q1 2021 and held it in 2 quarters. The position peaked at $927K in Q2 2021. 26 funds tracked by Wall St. Rank hold GRNAW as of Q3 2021.

  • Adage Capital Partners reported no remaining GreenLight Biosciences Holdings, PBC Warrant position as of Q3 2021 after selling out during the quarter.
  • Adage Capital Partners sold 858,334 GreenLight Biosciences Holdings, PBC Warrant shares in Q3 2021, an estimated $927K.
  • Adage Capital Partners first reported a position in GreenLight Biosciences Holdings, PBC Warrant in Q1 2021 and held it in 2 quarters.
  • Adage Capital Partners's GreenLight Biosciences Holdings, PBC Warrant position peaked at $927K in Q2 2021.
  • 26 funds tracked by Wall St. Rank held GreenLight Biosciences Holdings, PBC Warrant as of Q3 2021.

Based on Adage Capital Partners's 13F filing for Q3 2021, filed 15 Nov 2021.